QLT Inc: Premium Company Profile

Publication Date	January 2008
Publisher	Datamonitor
Product Type	Databook
Pages	55
ISBN Number	not applicable
Product Code	DAT09545

Price

£265.00
approximately: $532 | €333

PDF

PRINT £315 ($632 | €395)

Order above formats by FAX

Summary

Introduction

QLT was originally focused on discovering, developing and commercializing innovative therapies in the fields of ophthalmology and dermatology. In 2006, the company changed its focus to purely research and development by selling its manufacturing facility to Tolmar Pharmaceuticals.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

QLT has two marketed products: Visudyne for the treatment of wet age-related macular degeneration (AMD), pathologic myopia and presumed ocular histoplasmosis and Eligard for the palliative treatment of advanced prostate cancer.

QLT derives its revenues form of product sales (net product revenue and royalties), contract research and development, and licensing and milestones. The company enters into commercial license agreements with pharmaceutical and biotechnology companies to market its products.

The company's total revenues increased at a CAGR of 11.9% during 2002-2006, from $110.5 million to $175.1 million. This represents an absolute total growth of +$64.6 million for total revenues. The company's biggest contributor to revenue growth during 2002-2006 was product sales of Visudyne and Eligard.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Geographic Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
Overview
- Discovery and Product Development
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: QLT - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: QLT - Key Strategic Revenues, 2002-2006 ($ Mn)
- Table 1: QLT - Key Facts
- Table 2: QLT - Other Locations and Subsidiaries
- Table 3: QLT - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: QLT - Key Events Impacting Share Price Performance
- Table 5: QLT - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: QLT - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 7: QLT - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: QLT - Cash Flow, 2002-2006 ($ Mn)
- Table 9: QLT - Revenue Breakdown by Division, 2002-2006 ($ Mn)
- Table 10: QLT - Geographic Breakdown, 2002-2006 ($ Mn)
- Table 11: QLT - Marketed Products
- Table 12: QLT - in-house Pipeline Products
- Table 13: QLT - Historical Product Sales, 2002-2006 ($ Mn)
- Table 14: QLT - Key Competitors
- Table 15: QLT - Key Clients
- Table 16: QLT - Key Shareholders
- Table 17: QLT - SWOT Analysis Summary
- Table 18: QLT - Value Chain Analysis
- Table 19: QLT - Key Employees
- Table 20: QLT - Financial and Operational Overview